Interest in weight-loss medications is at an all-time high, with promising study results and inspiring success stories coming ...

As medical professionals and researchers continue searching for effective treatments, a drug called Ozempic (semaglutide) has emerged as a potential therapy. Originally approved for type 2 ...

Most Wall Street stocks were little changed and the dollar ticked up on Thursday as investors took some heart from trade talks between the United States, Japan and Italy, though the positive mood was ...

In addition, semaglutide (Ozempic, Novo Nordisk) received an expanded indication to reduce risk for worsening kidney disease, kidney failure and CV death for patients with diabetes and chronic ...

S&P 500 E-Mini futures (ESM25) are up +0.98%, and June Nasdaq 100 E-Mini futures (NQM25) are up +1.05% this morning, signaling a rebound from yesterday’s sell-off on Wall Street, while investors await ...

As medical professionals and researchers continue searching for effective treatments, a drug called Ozempic (semaglutide) has emerged as a potential therapy. Originally approved for type 2 diabetes ...